Skip to content

Pharminent

cropped-ChatGPT-Image-May-28-2026-10_46_23-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Commercial
  • The Rare Journey Needs a Special Pharmacy Partner
  • Commercial

The Rare Journey Needs a Special Pharmacy Partner

Drug Channels

Today's guest post is from Bansi Nagji, Chief Executive Officer at PANTHERx Rare.

CommercialRare DiseaseRead full story

pharminent March 27, 2026 (Last updated: March 30, 2026)

Drug Channels

Today’s guest post is from Bansi Nagji, Chief Executive Officer at PANTHERx Rare.

CommercialRare DiseaseRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Merck’s deal for Terns sparks debate over a possible biotech bidding war
Next: Novartis targets Xolair successor in buyout of startup Excellergy

Related Stories

  • Commercial

CVS obesity drug deal puts Lilly on equal footing with Novo

pharminent May 28, 2026
  • Commercial

Kardigan targets IPO to support cardiology pipeline progression

pharminent May 27, 2026
  • Commercial

Lilly UK recruits ex-England cricketer as obesity champion

pharminent May 15, 2026

You May Have Missed

  • Policy / Pricing

Eli Lilly issues data sharing ultimatum to 340B hospitals

pharminent June 2, 2026
  • M&A / Deals

Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug

pharminent June 2, 2026
  • Clinical Data

ASCO 2026: Kelonia presents positive in vivo CAR-T data in multiple myeloma

pharminent June 2, 2026
  • Clinical Data

ASCO26: In vivo oncology approaches continue to show promise

pharminent June 2, 2026
Copyright © 2026 All rights reserved. | ReviewNews by AF themes.